Highlights
IIA supported (ever)
About
Nanoparticle-based Therapeutics for Brain Cancer and CNS Disorders
Nanocarry is developing therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. The company’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond.
Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.
Identity
| Name | Nanocarry Therapeutics |
|---|---|
| Slug | nanocarry-therapeutics |
| Type / kind | startup |
| Crunchbase ID | nanocarry-therapeutics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkKrNgI8LDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Pinhas Sapir Street 3, Ness Ziona, Israel |
Web & social
| Website | https://nanocarry.com/ |
|---|---|
| https://www.linkedin.com/company/76550130 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business models
B2C
Tags
personalized-treatmentmedical-technologiescancertreatments
Funding
| Total raised | $1.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}